News
Auxilium Biotechnologies' microgravity 3D bioprinting technology could also have applications for tissue engineering, says ...
Researchers at UT Dallas say they’ve made a historic breakthrough in spinal cord injury recovery with a recent implant study.
Onward Medical announced today that two additional individuals with spinal cord injury (SCI) received its investigational ARC ...
A Cedar Rapids-based ear, nose and throat surgeon is among the first in the country – and the only in the Midwest – to offer ...
Global Implantable Infusion Pump Market Set for Steady Growth from 2022 to 2032, Driven by Chronic Disease Management and Technological Advances. The global implantable infusion pump market is poised ...
MacKenzie Maddry hopes to turn her own experience into a path of service. After graduation, she said she plans to pursue a career in nursing.
Approximately 30 million U.S. adults are believed to have sleep apnea, but only 6 million have been officially diagnosed. Ellen Tolbert is one of them. “About, I want to say, close to 15 years ago, I ...
15d
Zacks Investment Research on MSNAll You Need to Know About Inspire (INSP) Rating Upgrade to BuyInvestors might want to bet on Inspire Medical Systems (INSP), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...
Major adverse events remained common in patients with nonischemic cardiomyopathy implanted with an electronic device. Women and those who received cardiac resynchronization therapy had better ...
In this regard, RAFT, another randomized study evaluating CRT in mild HF, showed significant mortality reduction among class II HF patients implanted with a CRT device compared to ICD alone, likely as ...
First off, the device is fully approved ... The ENTs that have done performed Inspire V implant have responded very favorably and we expect a pretty seamless transition moving forward.
StockStory.org on MSN17d
Inspire Medical Systems’s (NYSE:INSP) Q1: Strong Sales, Stock SoarsMedical technology company Inspire Medical Systems (NYSE:INSP) announced in Q1 CY2025, with sales up 22.7% year on year to $201.3 million. The company expects the full year’s revenue to be around $947 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results